ATE204019T1 - Steigerung der transplantattoleranz durch schwein cytokine - Google Patents

Steigerung der transplantattoleranz durch schwein cytokine

Info

Publication number
ATE204019T1
ATE204019T1 AT93925071T AT93925071T ATE204019T1 AT E204019 T1 ATE204019 T1 AT E204019T1 AT 93925071 T AT93925071 T AT 93925071T AT 93925071 T AT93925071 T AT 93925071T AT E204019 T1 ATE204019 T1 AT E204019T1
Authority
AT
Austria
Prior art keywords
porcine
bone marrow
marrow cells
increase
cytokine
Prior art date
Application number
AT93925071T
Other languages
English (en)
Inventor
Paul D Ponath
Margaret D Rosa
Rodney L Monroy
Bernice Z Schacter
Robert J Hawley
Original Assignee
Biotransplant Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc filed Critical Biotransplant Inc
Application granted granted Critical
Publication of ATE204019T1 publication Critical patent/ATE204019T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/001Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT93925071T 1992-10-27 1993-10-26 Steigerung der transplantattoleranz durch schwein cytokine ATE204019T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96718892A 1992-10-27 1992-10-27
US08/133,979 US5589582A (en) 1992-10-27 1993-10-08 Polynucleotides en coding porcine cytokines
PCT/US1993/010295 WO1994009803A1 (en) 1992-10-27 1993-10-26 Enhancement of xenograft tolerance and porcine cytokines therefor

Publications (1)

Publication Number Publication Date
ATE204019T1 true ATE204019T1 (de) 2001-08-15

Family

ID=26831859

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93925071T ATE204019T1 (de) 1992-10-27 1993-10-26 Steigerung der transplantattoleranz durch schwein cytokine

Country Status (8)

Country Link
US (3) US5589582A (de)
EP (1) EP0669829B1 (de)
JP (1) JP3784063B2 (de)
AT (1) ATE204019T1 (de)
AU (2) AU5452194A (de)
CA (1) CA2147989C (de)
DE (1) DE69330566T2 (de)
WO (1) WO1994009803A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
GB9515839D0 (en) * 1995-08-02 1995-10-04 Q One Biotech Ltd Feline stem cell factor
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
US6428782B1 (en) 1997-05-23 2002-08-06 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
US6447767B1 (en) 1997-05-23 2002-09-10 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
WO1999009163A1 (en) * 1997-08-13 1999-02-25 Biotransplant, Inc. Porcine stem cell factor varients and recombinant cells expressing such polypeptides
WO1999009141A1 (en) * 1997-08-14 1999-02-25 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
US6248587B1 (en) * 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6703209B1 (en) * 1998-08-13 2004-03-09 Biotransplant, Inc. Porcine totipotent cells and method for long-term culture
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
GB2386125B (en) * 2000-11-22 2005-02-23 Geron Corp Tolerizing allografts of pluripotent stem cells
CA2442819A1 (en) * 2001-03-28 2002-10-24 Nextran, Inc. Elimination of endogenous porcine retrovirus
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
AU2002363322A1 (en) * 2001-10-26 2003-05-19 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
EP3170890A1 (de) 2002-08-21 2017-05-24 Revivicor, Inc. Schweine ohne expression von funktionaler alpha-1,3-galactosyltransferase
EP1685148A2 (de) 2003-11-05 2006-08-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Porcines isoglobosid-3-synthaseprotein, cdna, genomische organisation und regulatorische region
KR20070002057A (ko) 2004-03-17 2007-01-04 레비비코르 인코포레이션 기능성 알파 1,3 갈락토실트랜스펙션스페라제의 어떠한발현도 결여된 동물로부터 유래된 조직 산물
US7359066B2 (en) 2004-09-27 2008-04-15 Idc, Llc Electro-optical measurement of hysteresis in interferometric modulators
US7489849B2 (en) * 2004-11-03 2009-02-10 Adc Telecommunications, Inc. Fiber drop terminal
DK2059256T3 (en) 2006-08-11 2016-12-05 Life Sciences Res Partners Vzw Immunogenic peptides AND USE THEREOF FOR THE IMMUNE DISORDERS
AU2009214038B2 (en) 2008-02-14 2013-08-22 Katholieke Universiteit Leuven Elimination of immune responses to viral vectors
ES2626115T3 (es) * 2008-02-14 2017-07-24 Life Sciences Research Partners Vzw Péptidos inmunogénicos y su uso en trasplante
AU2009214039B2 (en) * 2008-02-14 2013-09-19 Katholieke Universiteit Leuven Immunogenic control of tumours and tumour cells
EP3075391A1 (de) * 2008-02-14 2016-10-05 Life Sciences Research Partners VZW Strategien zur verhinderung und/oder behandlung von immunantworten gegen lösliche allofaktoren
AU2009214041A1 (en) 2008-02-14 2009-08-20 Katholieke Universiteit Leuven CD4+ T-cells with cytolytic properties
AU2009214042B2 (en) 2008-02-14 2014-02-13 Katholieke Universiteit Leuven Immunotherapy targeting intracellular pathogens
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
CN103261218B (zh) 2010-11-25 2020-08-14 Imnate责任有限公司 免疫原性肽在预防和/或治疗疾病中的应用
US8911729B2 (en) * 2011-01-10 2014-12-16 The Regents Of The University Of Michigan Stem cell factor inhibitor
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
GB201309469D0 (en) 2013-05-28 2013-07-10 Imcyse Sa Detection of CD4+ T lymphocytes
GB201418433D0 (en) 2014-10-17 2014-12-03 Imcyse Sa Novel immunogenic peptides
US10729791B2 (en) 2015-05-18 2020-08-04 Imcyse Sa Animal models for evaluating pharmaceutical compounds
US11787849B2 (en) 2015-09-25 2023-10-17 Imcyse Sa Methods and compounds for eliminating immune responses to therapeutic agents
SG11201808710UA (en) 2016-04-19 2018-11-29 Imcyse Sa Novel immunogenic cd1d binding peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106733A (en) * 1987-06-25 1992-04-21 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
CA2045126A1 (en) * 1989-01-10 1990-07-11 Nicholas M. Gough Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
CA2114416C (en) * 1991-08-07 1998-07-07 W. French Anderson Retroviral vectors containing internal ribosome entry sites

Also Published As

Publication number Publication date
CA2147989A1 (en) 1994-05-11
DE69330566D1 (de) 2001-09-13
DE69330566T2 (de) 2002-06-27
US5858963A (en) 1999-01-12
AU703371B2 (en) 1999-03-25
AU5035998A (en) 1998-03-19
EP0669829A4 (de) 1997-05-07
JP3784063B2 (ja) 2006-06-07
US5863528A (en) 1999-01-26
EP0669829B1 (de) 2001-08-08
JPH08502650A (ja) 1996-03-26
US5589582A (en) 1996-12-31
WO1994009803A1 (en) 1994-05-11
AU5452194A (en) 1994-05-24
CA2147989C (en) 2002-10-22
EP0669829A1 (de) 1995-09-06

Similar Documents

Publication Publication Date Title
ATE204019T1 (de) Steigerung der transplantattoleranz durch schwein cytokine
ATE452190T1 (de) Verfahren zur isolierung und reinigung von g-csf
ATE297980T1 (de) Verfahren zur klonierung von schweinen
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
ATE199096T1 (de) Il-11 aus säugetier
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
DK0661989T3 (da) Proteinsammensætninger med vedvarende frigivelse
ATE321774T1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma- zeine, und diese exprimierende pflanzen
DE3485759D1 (de) Reinigung von rekombinanten interleukin-2.
ATE279441T1 (de) Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
DK12990D0 (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
MX9304209A (es) Composicion y metodo de tratamiento de hepatitis b.
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
DE69527640D1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
ATE110770T1 (de) Proliferation von cd4-lymfocyten.
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
ATE33842T1 (de) Immuninterferon und verfahren zu seiner reinigung.
Hawley et al. Polynucleotides en coding porcine cytokines
DK41890A (da) Immunosorbent og dets anvendelse
ATE253378T1 (de) Xenogene transplantation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee